EVUSHELD tixagevimab 100mg/mL and cilgavimab 100mg/mL solution for injection in 150mg single dose vials (378245)

ARTG ID 378245

ARTG Name

EVUSHELD tixagevimab 100mg/mL and cilgavimab 100mg/mL solution for injection in 150mg single dose vials

Product name

EVUSHELD tixagevimab 100mg/mL and cilgavimab 100mg/mL solution for injection in 150mg single dose vials

ARTG Date

26 February 2022

Registration Type

Medicine

Therapeutic good type

M

Ingredients

cilgavimab

tixagevimab

Licence category

REP

Licence status

A

Summary

Product information

Consumer medicine information

Related information

7 June 2022

Section 14 consent

AstraZeneca Pty Ltd, from CON-952, EVUSHELD tixagevimab 100 mg/ mL and cilgavimab 100 mg/ mL solution for injection in 150 mg single dose vials

Approved for Import and supply while noncompliant with standards. The consent is effective from the 7 June 2022 until 30 May 2023
7 February 2023

Section 14 consent

Brauer Natural Medicine Pty Ltd, from CON-1066, <div class="ExternalClass9CB9DD10B5D24AB08B87D735FB5F8CD8">EVUSHELD tixagevimab 100 mg/mL and cilgavimab 100 mg/mL solution for injection in 150 mg single dose vials</div>

Approved for Supply while noncompliant with standards. <div class="ExternalClassCC5798202D2A46E3B3325D4662DF8F90">The consent is effective from 7 February 2023 until 1 October 2026.</div>